| Number | Division | Year of performance | Agency | Project name |
|---|---|---|---|---|
| 10) | Government project | 2022~2024 | Korean Fund for Regenerative Medicine | Phase 1 clinical trial to evaluate the safety and effectiveness of CF-M801, the cell therapy agent based on the umbilical cord-derived osteoblasts, targeting patients with the femoral head osteonecrosis |
| 9) | Government project | 2022~2024 | Korean Fund for Regenerative Medicine | Development of the advanced bio-compounding agent based on the umbilical cord-derived osteoblasts for the treatment of osteoporotic fractures |
| 8) | Government project | 2018 | Ministry of SMEs and Startups | Culture system for the cell therapy agent and stem cell production |
| 7) | Government project | 2018~2020 | Korea Health Industry Development Institute | Establishment of manufacturing and production system for bone defect cell therapy agent |
| 6) | Government project | 2016~2019 | Korea Health Industry Development Institute | Development of the optimal culture system for stem cells using the multi-omics techniques |
| 5) | Government project | 2015~2018 | Agriculture, Food and Rural Technology Planning and Evaluation Institute | Development and commercialization of bone cell therapy using the pet dog adipose-derived mesenchymal stem cells |
| 4) | Service | 2016~2017 | Animal and Plant Quarantine Agency | Development of the next-generation cell therapy agent for equine musculoskeletal system using 3D differentiation technology |
| 3) | Government project | 2014~2015 | Korea Health Industry Development Institute | Hair follicle-derived epithelial cell culture and 3D hair follicle formation using 3D gel |
| 2) | Government project | 2012~2015 | Korea Health Industry Development Institute | Development of the synthetic biogel for self-proliferation and differentiation of mesenchymal stem cells, embryonic stem cells, and induced pluripotent stem cells |
| 1) | Government project | 2012~2015 | Korea Health Industry Development Institute | Development of stem cell therapy agent to treat the bone defects |